ImmuCell Corporation (Nasdaq: ICCC) plans to release unaudited financial results for the quarter ending June 30, 2025 on August 14, 2025, followed by a conference call on August 15, 2025 at 9:00 AM ET. The Company expects no changes to preliminary sales results disclosed on July 9, 2025. Quarterly Report on Form 10-Q will be filed on August 14, 2025.

Investors can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 AM ET on August 15, 2025. A teleconference replay will be available until August 22, 2025 at (877) 344-7529 (toll free) or (412) 317-0088 (international) using replay access code #5659118. An updated Corporate Presentation slide deck will be available on August 14, 2025.

ImmuCell Corporation aims to enhance the health and productivity of dairy and beef calves with products like First Defense®, providing Immediate Immunity™ to newborn calves, and Re-Tain®, a treatment for subclinical mastitis in dairy cows without FDA-required restrictions. For more information, visit the Company’s website or contact ImmuCell Corporation directly.

Read more at GlobeNewswire: ImmuCell to Announce Unaudited Financial Results for the